
|Articles|October 7, 2019
Patient outcomes and intraoperative use of phenylephrine/ketorolac 1%/0.3%
Author(s)Julianne Mobilian
ICYMI: Denise Visco, MD, shares the take-home message from her 2019 ASCRS presentation.
Advertisement
Denise Visco, MD, conducted a retrospective chart analysis of patients who received phenylephrine and ketorolac (OMIDRIA) during surgery-here's what she found.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Ocular Therapeutix accelerates NDA submission plans for AXPAXLI for wet AMD
2
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
3
FDA grants IDE approval to EyeYon Medical for its US clinical study of EndoArt
4
Study maps thermal dynamics of glaucoma laser treatments
5















































.png)


